NIT2 p.Thr2Ala
c.4A>G · rs199753663 · VCV2308276
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0561 | likely benign |
|---|---|---|
| REVEL | 0.193 | benign-leaning |
| SaProt | LLR -4.45 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.6 | GERP 0.44, phastCons 1 |
| Regional constraint | o/e 0.90 | unconstrained · MANE · 20 kb · p 0.07 · regional, not allelic |
| Overall | ||
| CADD | 14.41 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.0319% | 3,131 |
| Remaining individualsnot grpmax-eligible | 0.0208% | 4,812 |
| African / African-American | 0.00454% | 22,014 |
| South Asian | 0.0032% | 31,206 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NIT2
- Protein
- p.Thr2Ala
- Coding
- c.4A>G
- MANE Select
- NM_020202
- dbSNP
- rs199753663
- Type
- single nucleotide variant
- Location
- chr3:100334795 (GRCh38)
- Gene constraint
- LOEUF 1.249 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 97.62
Similar variants
- NIT2 p.Ala209Val Uncertain significance ★ ⚠ same type
- NIT2 p.Ala51Gly Uncertain significance ★ ⚠ same type
- NIT2 p.Ala51Val Uncertain significance ★ ⚠ same type
- NIT2 p.Arg157Gln Uncertain significance ★ ⚠ same type
- NIT2 p.Arg195Trp Uncertain significance ★ ⚠ same type
- NIT2 p.Arg210Trp Uncertain significance ★ same type
- NIT2 p.Arg23Cys Uncertain significance ★ ⚠ same type
- NIT2 p.Arg255Cys Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nit2-p-thr2ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown